Suppression of VEGF‐induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A

No abstract is available for this paper.

• Publication year

  1995

• Venue

  British Journal of Pharmacology

• Publication date

  1995-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.1995.tb13221.xPMID 7533611PMCID PMC1510224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat

  1995cited by this paper
• Angiosuppressive therapy for cancer.

  1994cited by this paper
• A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions.

  1994cited by this paper
• Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies

  1994cited by this paper
• Angiosuppressive and Antiproliferative Actions of Suramin: A Growth Factor Antagonist

  1993cited by this paper
• Regulation of NANC neural bronchoconstriction in vivo in the guinea‐pig: involvement of nitric oxide, vasoactive intestinal peptide and soluble guanylyl cyclase

  1993cited by this paper
• High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

  1993cited by this paper
• Vascular permeability factor (VPF, VEGF) in tumor biology

  1993cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.

  1993cited by this paper
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

  1993cited by this paper
• [Leu8]des‐Arg9‐bradykinin inhibits the angiogenic effect of bradykinin and interleukin‐1 in rats

  1993cited by this paper
• Stimulation of angiogenesis by substance P and interleukin‐1 in the rat and its inhibition by NK1 or interleukin‐1 receptor antagonists

  1993cited by this paper
• Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

  1993cited by this paper
• Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.

  1993cited by this paper
• Molecular and biological properties of the vascular endothelial growth factor family of proteins.

  1992cited by this paper
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

  1992cited by this paper
• Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.

  1992cited by this paper
• Tyrosine phosphorylation is required for mast cell activation by Fc epsilon RI cross-linking.

  1992cited by this paper
• Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo

  1992cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Characterization and applications of the disc angiogenesis system.

  1992cited by this paper
• Tyrosine Phosphorylation is Required for Mast Cell Activation by FcεRI Cross-Linking.

  1992cited by this paper
• Hypotensive activity of fibroblast growth factor.

  1991cited by this paper
• Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors

  1991cited by this paper
• Specific binding of vascular permeability factor to endothelial cells.

  1991cited by this paper
• Vascular permeability factor: A unique regulator of blood vessel function

  1991cited by this paper
• Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells.

  1990cited by this paper
• Inhibition of tyrosine kinase and epidermal growth factor receptor internalization by lavendustin A methyl ester in cultured A431 cells.

  1990cited by this paper
• Suramin: prototype of a new generation of antitumor compounds.

  1990cited by this paper
• Suramin: prototype of a new generation of antitumor compounds.

  1990cited by this paper
• Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

  1989cited by this paper
• Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo.

  1989cited by this paper
• Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus.

  1989cited by this paper
• Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).

  1989cited by this paper
• Angiogenic factors.

  1987cited by this paper
• Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells

  1987cited by this paper
• Quantitative in-vivo studies on angiogenesis in a rat sponge model.

  1987cited by this paper
• Sampling schemes for estimating nerve fibre size. I. Methods for nerve trunks of mixed fascicularity.

  1984cited by this paper
• Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors

  1972cited by this paper

• Computational identification and analysis of CNP0269688 as a natural product inhibitor disrupting the interaction between the HIV matrix domain and tRNA

  2024cites this paper
• Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitro

  2020cites this paper
• New methods for objective angiogenesis evaluation of rat nerves using microcomputed tomography scanning and conventional photography

  2019cites this paper
• E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma

  2017cites this paper
• Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect

  2017cites this paper
• Alteration of red blood cell microrheology by anti-tumor chemotherapy drugs

  2016influential citation
• Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells

  2016cites this paper
• Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy

  2015cites this paper
• TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cells.

  2014cites this paper
• Signaling pathways regulating red blood cell aggregation

  2014cites this paper
• Expressão histoimunológica de proteínas relacionadas à hipóxia tecidual em juvenis de Trachinotus carolinus (Linnaeus, 1766) (Perciformes, Carangidae) em função do aquecimento gradual de temperatura

  2013cites this paper
• Role molecular signaling pathways in changes of red blood cell deformability

  2013cites this paper
• Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.

  2013cites this paper
• Platelets and Anti-Angiogenic Resistance in Ovarian Carcinoma

  2012cites this paper
• Role of protein kinases of human red cell membrane in deformability and aggregation changes

  2012cites this paper
• Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.

  2012cites this paper
• Modelling angiogenesis in inflammation

  2008cites this paper
• Effects of the protein tyrosine kinase inhibitor genistein and taurine on retinal function in isolated superfused retina

  2007cites this paper
• Effect of Basic Fibroblast Growth Factor, Vascular Endothelial Growth Factor/Vascular Permeability Factor, and Host Microenvironment

  2007cites this paper
• endothelial growth factor in eye disease Role of vascular permeability factor/vascular

  2006cites this paper
• Murine Chemokine CXCL2/KC Is a Surrogate Marker for Angiogenic Activity in the Inflammatory Granulation Tissue

  2005cites this paper
• Natural products as angiogenesis modulators.

  2005cites this paper
• Toxicological overview of cigarette smoking on angiogenesis.

  2005cites this paper
• Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents

  2004cites this paper
• Cancer anti-angiogenic therapy.

  2004cites this paper
• Delayed angiogenesis in aging rats and therapeutic effect of adenoviral gene transfer of VEGF.

  2004cites this paper
• Two Rice GRAS Family Genes Responsive to N-Acetylchitooligosaccharide Elicitor are Induced by Phytoactive Gibberellins: Evidence for Cross-Talk Between Elicitor and Gibberellin Signaling in Rice Cells

  2004cites this paper
• Targeting of Mitogen‐Activated Protein Kinases and Phosphatidylinositol 3 Kinase Inhibits Hepatocyte Growth Factor/Scatter Factor‐Induced Angiogenesis

  2003cites this paper
• Endothelial dysfunction: Many ways to correct-trends that promise

  2003cites this paper
• Plasma membrane Ca2+-ATPase isoform 4b is phosphorylated on tyrosine 1176 in activated human platelets

  2003cites this paper
• Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor

  2003cites this paper
• Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis.

  2003cites this paper
• Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor

  2002cites this paper
• Angiogenesis-Regulating Cytokines

  2002cites this paper
• Control of Angiogenesis by Microbial Products

  2002cites this paper
• Effects of Protein Tyrosine Kinase Inhibitor Genistein on Retinal Function in Superfused Vertebrate Retina

  2001cites this paper
• In Vivo Absence of Synergism Between Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor

  2001cites this paper
• Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis

  2001cites this paper
• The control and manipulation of angiogenesis in the primate corpus luteum

  2001cites this paper
• Synergistic Induction of t-PA by Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor and Localization of t-PA to Weibel-Palade Bodies in Bovine Microvascular Endothelial Cells

  2001cites this paper
• Fibroblast Growth Factor 2 Activation of Stromal Cell Vascular Endothelial Growth Factor Expression and Angiogenesis

  2001cites this paper
• Thapsigargin inhibits angiogenesis in the rat isolated aorta: studies on the role of intracellular calcium pools.

  2001cites this paper
• Effect of intrahepatic omental implantation on angiogenesis in rat liver with hepatic artery ligation

  2001cites this paper
• Extracellular Proteolysis and Angiogenesis

  2001cites this paper
• Endothelin and Its Inhibitors

  2001cites this paper
• The Roles of Endothelins in Proliferation, Apoptosis, and Angiogenesis

  2001cites this paper
• Influence of muscarinic agonists and tyrosine kinase inhibitors on L-type Ca(2+)Channels in human and bovine trabecular meshwork cells.

  2000cites this paper
• Evaluation of angiogenesis by intrahepatic omental implantation in rat liver transplantation.

  2000cites this paper
• Rat sponge implant model: a new system for evaluating angiogenic gene transfer.

  2000cites this paper
• VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy

  2000cites this paper
• Inhibition of vascular endothelial growth factor activity by transfection with the soluble FLT-1 gene.

  2000cites this paper
• A Pilot Trial of Suramin in Metastatic Breast Cancer to Assess Antiangiogenic Activity in Individual Patients

  2000cites this paper
• Vaskuläre Veränderungen bei der diabetischen Retinopathie: Die zellulären und humoralen Interaktionsmechanismen in Antwort auf die Stoffwechselveränderungen

  2000cites this paper
• Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo

  1999cites this paper
• Tyrosine kinase inhibitors block sperm-induced egg activation in Xenopus laevis.

  1999cites this paper
• Epidermal growth factor receptor relocalization and kinase activity are necessary for directional migration of keratinocytes in DC electric fields.

  1999cites this paper
• Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors

  1999cites this paper
• Vascular endothelial growth factor (VEGF)‐C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity

  1998cites this paper
• Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.

  1998cites this paper
• Angiogenesis: possibilities for therapeutic interventions

  1998cites this paper
• Clinical research on antiangiogenic therapy.

  1998cites this paper
• Antagonising the expression of VEGF in pathological angiogenesis

  1998cites this paper
• Significance of angiogenesis in cancer therapy

  1998cites this paper
• Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.

  1998cites this paper
• Natural Products as Angiogenesis Inhibitors

  1998cites this paper
• Uptake of [3H]-adrenaline by freshly isolated rat hepatocytes: putative involvement of P-glycoprotein.

  1998cites this paper
• Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo

  1997cites this paper
• The codependence of angiogenesis and chronic inflammation

  1997cites this paper
• Angiogenese und Angiogenesehemmung im Auge

  1997cites this paper
• The role of vascular cell integrins αvß3 and αvß5 in angiogenesis

  1997cites this paper
• Angiogenesis: new aspects relating to its initiation and control

  1997cites this paper
• [Angiogenesis and inhibition of angiogenesis in the eye].

  1997cites this paper
• Role of vascular permeability factor/vascular endothelial growth factor in eye disease

  1997cites this paper
• The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis.

  1997cites this paper
• Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.

  1997cites this paper
• Receptor tyrosine kinases as targets for inhibition of angiogenesis

  1997cites this paper
• Similar clinical outcomes in African-American and non-African-American males treated with suramin for metastatic prostate cancer.

  1997cites this paper
• Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.

  1996cites this paper
• Potent inhibition of angiogenesis by wortmannin, a fungal metabolite.

  1996cites this paper
• Regulation of Angiogenesis

  1996cites this paper
• Angiogenic factors in moyamoya disease.

  1996cites this paper
• Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins‐1 and −3 and angiotensin II in a rat sponge model

  1996cites this paper
• Vascular endothelial growth factor: environmental controls and effects in angiogenesis.

  1996cites this paper
• Inward transport of [3H]‐1‐methyl‐4‐phenylpyridinium in rat isolated hepatocytes: putative involvement of a P‐glycoprotein transporter

  1996cites this paper
• Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium.

  1996cites this paper
• Angiogenesis-regulating cytokines: activities and interactions.

  1996cites this paper
• Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers.

  1995cites this paper
• Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy.

  1995cites this paper
• Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat

  1995cites this paper